Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN125,6125,781,02
Msft0,13
Nokia11,811,940,68
IBM-5,05
Mercedes-Benz Group AG44,9744,9851,51
PFE-2,74
19.06.2026 18:12:06
Indexy online
AD Index online
select
AD Index online
 

  • 19.06.2026 2:04:00
Estee Lauder (EL, NY Consolidated)
Poslední obchod Změna (%) Změna (USD) Objem obchodů (USD)
84,81 2,85 2,35 357 291 665
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 22.06.2026
Popis společnosti

Business Summary: The Estee Lauder Companies Inc. is a manufacturer, marketer and seller of skin care, makeup, fragrance and hair care products. Its products are sold in over 150 countries and territories under a number of brand names, including Estee Lauder, Aramis, Clinique, Lab Series, Origins, M.A.C, Bobbi Brown Cosmetics, La Mer, Aveda, Jo Malone London, Bumble and bumble, Darphin Paris, TOM FORD, Smashbox, AERIN Beauty, Le Labo, Editions de Parfums Frederic Malle, GLAMGLOW, Kilian Paris, Too Faced, Dr.Jart+, and the DECIEM family of brands, including The Ordinary and NIOD, and BALMAIN Beauty. It is a license for fragrances, cosmetics and/or related products for AERIN, BALMAIN, and Dr. Andrew Weil. Its skin care products include moisturizers, serums, cleansers, toners, exfoliators, facial masks, body care, sun care products and others. Its makeup products include foundations, powders, concealers and setting sprays, lipsticks, lip liners and lip glosses, and mascaras, eyeshadows and eyeliners.
Financial Summary: BRIEF: For the nine months ended 31 March 2026, Estee Lauder Companies Inc revenues increased 5% to $11.42B. Net income before extraordinary items totaled $349M vs. loss of $587M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net Income reflects Fragrance segment income totaling $21M vs. loss of $414M, Makeup segment loss decrease of 98% to $3M.



  • Poslední aktualizace: 22.06.2026
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chairman of the Board, President, Chief Executive OfficerRobert Bradway6301.01.201310.04.2007
Chief Financial Officer, Executive Vice PresidentThomas Dittrich6201.09.202601.09.2026
Chief Financial Officer, Executive Vice PresidentPeter Griffith6701.01.202023.10.2019
Executive Vice President, Co-Chief Technology OfficerDavid Reese6301.06.202626.07.2018
Executive Vice President - Research and Development, Artificial Intelligence and DataJames Bradner5401.06.202618.12.2023
Executive Vice President, General Counsel, SecretaryJonathan Graham65
Executive Vice President - Amgen Global Markets and PolicyMurdo Gordon5901.06.202603.09.2018
Executive Vice President - OperationsEsteban Santos58
Senior Vice President, Co-Chief Technology OfficerSean Bruich-01.06.202601.06.2026
Senior Vice President, Chief Compliance OfficerNancy Grygiel5801.01.2020